As initial validation, we used our method to predict sample cell type identity in two RNA-Seq datasets derived from purified cell types: one derived from from purified cortical cell types in mice (n=17: two samples per cell type and 3 whole brain samples: GSE52564) [18], and one derived from 466 single-cells dissociated from freshly-resected human cortex (GSE67835) [2]. The RNA-Seq data that we downloaded from GEO was already in the format of FPKM values (Fragments Per Kilobase of exon model per million mapped fragments) [18] or counts per gene [2]. To stabilize the variance in the data, we used a log(2) transformation (after adding 1), and then filtered out the data for any genes that completely lacked variation across samples (sd=0; final gene count: GSE52564: 17148, GSE67835: 21627). Then we applied the methods now found in the BrainInABlender package, and examined the correlation between each of the cell type indices and sample cell type identity (excluding the fetal, whole brain, and "hybrid" cells). The code for these analyses can be found at https://github.com/hagenaue/CellTypeAnalyses_Darmanis and https://github.com/hagenaue/CellTypeAnalyses_Zhang.
Additional methods: Detailed preprocessing methods for the transcriptomic datasets
RNA-Seq data from purified cell types (GSE52564 and GSE67835)
As initial validation, we used our method to predict sample cell type identity in two RNA-Seq datasets derived from purified cell types: one derived from from purified cortical cell types in mice (n=17: two samples per cell type and 3 whole brain samples: GSE52564) [18] , and one derived from 466 single-cells dissociated from freshly-resected human cortex (GSE67835) [2] . The RNA-Seq data that we downloaded from GEO was already in the format of FPKM values (Fragments Per Kilobase of exon model per million mapped fragments) [18] or counts per gene [2] . To stabilize the variance in the data, we used a log(2) transformation (after adding 1), and then filtered out the data for any genes that completely lacked variation across samples (sd=0; final gene count: GSE52564: 17148, GSE67835: 21627). Then we applied the methods now found in the BrainInABlender package, and examined the correlation between each of the cell type indices and sample cell type identity (excluding the fetal, whole brain, and "hybrid" cells). The code for these analyses can be found at https://github.com/hagenaue/CellTypeAnalyses_Darmanis and https://github.com/hagenaue/CellTypeAnalyses_Zhang.
Microarray data from artificial cell mixtures (GSE19380)
As further validation, we determined whether relative cell type balance could be accurately deciphered from microarray data for samples containing artificially-generated mixtures of cultured cells from the cerebral cortices of rat P1 pups (GSE19380, [12] ). The microarray profiling was performed using a Affymetrix Rat Genome 230 2.0 Array. According to the methods on GEO, this data had already undergone probeset summarization and normalization using robust multi-array averaging (RMA, affy package [87] ), including background subtraction, summarization by median polish, log(2) transformation, and quantile normalization. We then predicted the cell content of each sample from the microarray data using BrainInABlender, and correlated these predictions with the actual percent of each cell type found in the mixtures (Fig 5 in main text) . The code for these analyses can be found at:
https://github.com/hagenaue/CellTypeAnalyses_KuhnMixtures/tree/master.
Pritzker dorsolateral prefrontal cortex microarray dataset (GSE92538)
The original dataset included tissue from 172 high-quality human post-mortem brains donated to the Brain Donor Program at the University of California, Irvine with the consent of the next of kin.
Frozen coronal slabs were macro-dissected to obtain dorsolateral prefrontal cortex samples. Clinical information was obtained from medical examiners, coroners' medical records, and a family member.
Patients were diagnosed with either Major Depressive Disorder, Bipolar Disorder, or Schizophrenia by consensus based on criteria from the Diagnostic and Statistical Manual of Mental Disorders [88] . Due to the extended nature of this study, this sample collection occurred in waves ("cohorts") over a period of many years.
As described previously [28, 62] , total RNA from these samples was then distributed to laboratories at three different institutions (University of Michigan (UM), University of California-Davis (UCD), University of California-Irvine (UCI)) for hybridization to either Affymetrix HT-U133A or HTU133Plus-v2 chips (1-5 replicates per sample, n=367). Before conducting the current analysis, the subset of probes found on both the Affymetrix HT-U133A and HT-U133Plus-v2 chips was extracted, reannotated for probe-to-transcript correspondance [89] , summarized using RMA [87] , log(2)-transformed, quantile normalized, and gender-checked. Then, 15 batches of highly-correlated samples were identified that were defined by a combination of cohort, chip, and laboratory (Fig A) . Samples that exhibited markedly low average sample-sample correlation coefficients (<0.85: outliers) were removed from the dataset, including data from one batch that exhibited overall low samplesample correlation coefficients with other batches and duplicate microarrays. The batch effects were then subtracted out using median-centering (detailed procedure: [62] ) and the replicate samples were averaged for each subject. Our current analyses began with this sample-level summary gene expression data (GSE92538). We further removed data from any subjects lacking information regarding critical pre-or post-mortem variables necessary for our analysis (final sample size: n=157). The code for these analyses can be found at https://github.com/hagenaue/CellTypeAnalyses_PritzkerAffyDLPFC.
Allen Brain Atlas cross-regional microarray dataset
The Allen Brain Atlas microarray data was downloaded from http://human.brainmap.org/microarray/search in December 2015. This microarray survey was performed in brain-specific batches, with multiple batches per subject. To remove technical variation across batches, a variety of normalization procedures had been performed by the original authors both within and across batches using internal controls, as well as across subjects [90] . The dataset available for download had already been log(2)-transformed and converted to z-scores using the average and standard deviation for each probe. These normalization procedures were designed to remove technical artifacts while best preserving cross-regional effects in the data, but the full information about relative levels of expression within an individual sample were unavailable and the effects of subject-level variables (such as age and pH) were likely to be de-emphasized due to the inability to fully separate out subject and batch during the normalization process. The 30,000 probes mapped onto 18,787 unique genes (as determined by gene symbol). The code for these analyses can be found at https://github.com/hagenaue/CellTypeAnalyses_AllenBrainAtlas.
Human cortical microarray dataset GSE53987 (described in Lanz et al. [30])
The full publicly-available dataset GSE53987 [30] contained Affymetrix U133Plus2 microarray data from 205 post-mortem human brain samples from three brain regions: the DLPFC (Brodmann Area 46, focusing on gray matter only (Lanz T.A., personal communication)), the hippocampus, and the striatum. These samples were collected by the University of Pittsburgh brain bank. For the purposes of our current analysis, we only downloaded the microarray .CEL files for the dorsolateral prefrontal cortex samples. We summarized these data with RMA [87] using a custom up-to-date chip definition file (.cdf)
to define probe-to-transcript correspondence ("hgu133plus2hsentrezgcdf_19.0.0.tar.gz" from http://nmgr.bioinformatics.nl/NuGO_R.html [89] ). This process included background subtraction, log(2)-transformation, and quantile normalization. Gene Symbol annotation for probeset Entrez gene ids were provided by the R package org.Hs.eg.db. To control for technical variation, the sample processing batches were estimated using the microarray chip scan dates extracted from the .CEL files (using the function protocolData in the GEOquery package [91] ), but all chips for the DLPFC were scanned on the same date. RNA degradation was estimated using the R package AffyRNADegradation [33] . During quality control, two samples were removed -GSM1304979 had a range of sample-sample correlations that was
Additional validation for the BrainInABlender method
BrainInABlender can predict relative cell content in datasets from purified cells and In Silico mixtures
As initial validation, we used the BrainInABlender method to predict the relative balance of cell types in samples with known cell content (purified cells and artificial cell mixtures). To do this analysis, we used two RNA-Seq datasets: one derived from from purified cortical cell types in mice (GSE52564)
[18], and one derived from human single-cell RNA-Seq (GSE67835) [2] . In general, we found that the statistical cell type indices easily predicted the cell type identities of the original samples (Fig B) . The correlation between each of the cell type indices and their respective cell type was very strong within the mouse purified, pooled cell type dataset (R 2 between 0.41-0.90) and moderate in the noisier human single-cell dataset (R 2 between 0.14-0.67), but typically still much higher than the correlation with other cell types. This was true regardless of the publication from which the cell type specific genes were derived: cell type specific gene lists derived from publications using different species (human vs. mouse), values indicating how much of the variance within any particular cell type index (row) is explained by a particular sample cell type (column, NFO: "newly-formed oligodendrocyte"). The cell type indices are named after their origin (primary cell type, subtype, and publication), and the primary cell type category is further identified by color (lavender: astrocytes, orange: endothelial, green: microglia, yellow: mural, purple: neuron_all, blue: neuron_projection, red: neuron_interneuron, pink: oligodendrocyte, white: oligodendrocyte progenitor cell (OPC)). For further analyses, individual cell type indices were averaged within each of the primary cell type categories to produce ten consolidated primary cell-type indices for each sample. To perform this consolidation, we also removed any transcripts that were identified as "cell type specific" to multiple primary cell type categories (Fig C) .
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percentage of their respective cell type included in our artificial mixtures in a linear manner across a range of values likely to encompass the true proportion of these cells in our cortical samples. The amount of noise present in these predictions varied by data type, with the predictions generated from single-cell data having substantially more noise than those generated from pooled, purified cells, but most of the data (+/-1 stdev) still fell within +/-5% of the prediction (Fig D) . Therefore, we concluded that cell type indices are a relatively easy manner to predict relative cell type balance across samples. Although we generated our method independently to address microarray analysis questions that arose within the Pritzker Neuropsychiatric Consortium, we later discovered that it was quite similar to the technique of population-specific expression analysis (PSEA, [12]) with several notable differences.
Similar to our method, PSEA is a carefully-validated analysis method which aims to estimate cell typedifferentiated disease effects from microarray data derived from brain tissue of heterogeneous composition and approaches this problem by including the averaged, normalized expression of cell type specific markers within a larger linear model that is used to estimate differential expression in microarray data [10-12]. Analyses using PSEA similarly indicated that individual variability in neuronal, astrocytic, oligodendrocytic, and microglial cell content was sufficient to account for substantial variability in the vast majority of probesets in microarray data from human brain samples, even within non-diseased samples [12] . The differences between our techniques are mostly due to the recent growth of the literature documenting cell type specific expression in brain cell types. PSEA uses a very small set of markers (4-7)
to represent each cell type, and screens these markers for tight co-expression within the dataset of interest, since co-expression networks have been previously demonstrated to often represent cell type signatures in the data [94] . This is essential for the analysis of microarray data for brain regions that have not been well characterized for cell type specific expression (e.g., the substantia nigra), but risks the possibility of closely tracking variability in a particular cell function instead of cell content (as described in our results related to aging). Our analysis focused on the well-studied cortex, thus enabling us to utilize hundreds of cell type specific markers derived from a variety of experimental techniques. However, within RNA-Seq, counts of zero are common and therefore we suspected that the ratio-form of normalization used by PSEA might not function optimally for this data type.
Therefore, we decided to run a head-to-head comparison of our method and PSEA using the human single-cell RNA-Seq dataset [2] . To make the comparison as interpretable as possible, we used the same list of cell type specific genes for both methods (the genes in our database used to construct
BrainInABlender's consolidated cell type indices). In order to avoid circular reasoning, we also excluded any cell type specific genes that had originally been identified by the publication currently used as the test
. Then we used the marker() function from the PSEA package to calculate the "Reference Signal" for the most common primary categories of cell types (astrocytes, endothelial cells, microglia, mature oligodendrocytes, and neurons). For our method, we used a procedure similar to BrainInABlender.
We applied a z-score transformation to the data for each gene (mean=0, sd=1), and then either averaged by the primary cell type category (to conduct an analysis paralleling PSEA), or averaged the data from the cell type specific genes identified by each publication, followed by averaging by primary cell type category (to create consolidated cell type indices like BrainInABlender).
To compare the efficacy of each method, we ran a linear model to determine the percentage of variation in the population "reference signal" (PSEA) or "cell type index" (our method) accounted for by the cell type identities assigned to each cell in the original publication [2]. We found that both the population reference signals (PSEA) and cell type indices (our method) for each cell were strongly related to their previously-assigned cell type identity, but in general the relationship was stronger when using our method: on average, 34% of the variation in the PSEA reference signal for each cell type was accounted for by cell identity, whereas an average of either 45% or 49% of the variation in our cell type indices was accounted for by cell identity using either the simplified or consolidated versions of our method, respectively (Fig E part A) . An illustration of this improvement can be found in Fig E part B: note the presence of extreme outliers in the PSEA population reference signal. We conclude that the simple use of a different normalization method is sufficient to make our method more effective at predicting cell type balance in some datasets. We also find that averaging the predictions drawn from the cell type specific genes identified by multiple publications into a consolidated index produces some additional improvement.
• The$same$cell$type$specific$genes$were$used$in$all$methods : 1) the "population reference signal" generated by PSEA, 2) a simplified version of our method that is meant to be relatively analogous to PSEA (a simple average of the z-score-transformed data for all genes specific to a particular cell type in our database), 3) the version of our method used in this manuscript, which consolidates the predictions derived from the cell type specific genes identified in different publications.
A. For each of these methods of predicting relative cell content (columns) the table provides the percentage of variation (R 2 ) that is accounted for by the original cell type identities of the samples provided by the publication [2] for predictions for each of the major cell types (rows). Overall, there is a strong relationship between the predictions generated by all methods and sample cell type identity, but the method used in this manuscript produces predictions that best fit sample cell type. B. As an example, boxplots illustrate the distribution of each of the predictions for neuronal content across samples identified as different cell types in the original publication([2], x-axis). Note the presence of several extreme outliers (red arrows) in the predictions produced by PSEA-a similar pattern was seen for all other cell types.
Using similar methodology, we also calculated the population "reference signal" with PSEA for microarray data from artificially-created mixtures of cultured cells (GSE19380). The results strongly tracked the actual cell content of the mixed samples (Fig F) in a manner that was not strikingly better or worse than the predictions made using BrainInABlender (Fig 6) . This again drives home the fact that the ratio-based normalization methods used in PSEA are particularly incompatible with low count data in RNA-Seq -results derived from microarray data are fine.
Fig F.
Relative cell content predictions made using PSEA and our cell type specific gene lists. Using a microarray dataset derived from samples that contained artificially-generated mixtures of cultured cells (GSE19380; [12]), we found that the relative cell content predictions ("cell type reference signal") produced by PSEA closely reflected actual known content, similar to the predictions made by BrainInABlender (Fig 6) .
Does the reference dataset matter? There is a strong convergence of cell content predictions derived from cell type specific transcripts identified by different publications
Similar to what we observed during our validation analyses using data from purified cell types, we found that the predicted cell content for the post-mortem human cortical samples ("cell type indices") was similar regardless of the methodology used to generate the cell type specific gene lists used in the predictions. Within all five of the human cortical transcriptomic datasets, there was a strong positive correlation between cell type indices representing the same cell type, even when the predictions were derived using cell type specific gene lists from different species, cell type purification strategies, and platforms. Clustering within broad cell type categories was clear using visual inspection of the correlation matrices (Fig G) , hierarchical clustering, or consensus clustering (ConsensusClusterPlus: [95] ) and persisted even after removing data from genes identified as cell type specific in multiple publications (e.g., gene expression identified as astrocyte-expression in both Cahoy_Astrocyte and Zhang_Astrocyte; Fig H) . In some datasets, the cell type indices for support cell subcategories were nicely clustered and in others they were difficult to fully differentiate (Fig G) . Clustering was not able to reliably discern neuronal subcategories (interneurons, projection neurons) in any dataset. Similar to our previous validation analyses, oligodendrocyte progenitor cell indices derived from different publications did not strongly correlate with each other, perhaps due to heterogeneity in the progenitor cell types sampled by the original publications. Many of the top gene probesets that we found to be related to each of the cell type indices are already known to be associated with that cell type in previous publications, validating our methodology.
A.

Neurons
Importantly, this is true even when the genes were not included in the original list of cell type specific genes used to generate the index. For example, we found that HLA-E and EPAS1 were both strongly associated with our endothelial index, and both are known to be involved in endothelial cell activation [96] [97] . NOTCH2, one of the top astrocyte-related genes, promotes astrocytic cell lineage [98] , and APOE is primarily secreted by astrocytes in the central nervous system [99] . One of the top interneuron genes, LHX6, is specifically enriched in parvalbumin-containing interneurons [2] . Another top interneuron gene, ERBB4, controls the development of GABA circuitry in the cortex [100] . Many top neuron-related genes relate to synaptic function (SYT1, SYNGR3, NRXN1; http://www.genecards.org/).
The top projection neuron-related gene, PDE2A, is preferentially expressed in cortical pyramidal neurons [101] , and KIF21B is a kinesin found in the dendrites of pyramidal neurons [102] . We also rediscovered probesets representing genes that were listed as alternative orthologs to those included in our original cell type specific gene lists (oligodendrocytes: EVI2A vs.CTD-2370N5.3, microglia: LAIR1 vs. LAIR2, mural cells: COL18A1 vs. COL15A1, ACTA2 vs. ACTG1). Altogether, these results suggest that our cell type indices were associated with the variability of transcripts in the cortex that represented particular cell types and could re-identify known cell type specific markers.
Additional figures and results
Inferred cell type composition explains a large percentage of the sample-sample variability in microarray data from macro-dissected human cortical tissue
Within the four non-Pritzker human cortical tissue datasets, the relationships between the top principal components of variation and the consolidated cell type indices were similarly strong (Fig J) , even though these datasets had received less preprocessing to remove the effects of technical variation. PC1 accounted for 13% of the variation in the dataset and was highly correlated with predicted astrocyte content (PC1 vs. astrocyte index: R 2 =0.80, p<4.6e-24). In GSE21138 (39), which also had samples derived exclusively from gray-matter-only dissections, PC1 accounted for 23% of the variation in the dataset and was strongly related to technical variation (batch), but PC2, which accounted for 14% of the variation in the dataset, again represented a gradient from samples with high predicted support cell content to high predicted neuronal content (PC2 vs. astrocyte: R 2 =0.56, p<8.3e-11, PC2 vs. neuron_all: R 2 =0.54, p<2.3e-10). Finally, within the CMC RNA-Seq dataset, PC1 accounted for 16% of the variation in the dataset and was highly correlated with predicted projection neuron content (PC1 vs.
Neuron_Projection: R 2 =0.54, p=5.77e-104). When digging deeper, we found that none of the original 38 publication-specific cell type indices were noticeably superior to the consolidated indices when predicting the principal components of variation in the datasets. Human-derived indices did not outperform mouse-derived indices, and indices derived from studies using stricter definitions of cell type specificity (fold enrichment cut-off in Fig 1) did not outperform less strict indices.
It is difficult to discriminate between changes in cell type balance and cell-type specific function Fig K. The predicted decrease in neuronal cell content in relationship to age is unlikely to be fully explained by synaptic atrophy. Within the list of neuron-specific genes, 240 functional clusters were identified using DAVID. A) The genes in 19 out of the top 20 functional clusters showed decreased expression with age on average, as determined within a linear model that controlled for traditional confounds ("Model 2"). Depicted is the average effect of age +/-SE for each cluster (asterisks: p<0.05, blue=down-regulation, red=up-regulation). Overall, 76% of all 240 functional clusters showed a negative relationship with age on average (S4 Table) . B.) We blindly chose 29 functional clusters that were clearly 
B.
related to dendritic/axonal functions and 41 functional clusters that seemed distinctly unrelated to dendritic/axonal functions. Transcripts from both classifications showed an average decrease in expression with age (p=9.197e-05, p=0.008756, respectively), but the decrease was larger for transcripts associated with dendritic/axonal-related functions (p=0.02339). Depicted is the average effect of age +/-SE for each classification of cluster.
Previously-documented psychiatric effects on cortical gene expression within particular cortical cell types or within macrodissected prefrontal cortex
Fig L.
Gene lists used to assess whether controlling for cell type while performing differential expression analyses enhances the detection of previously-documented psychiatric effects on cortical gene expression. These lists include genes with documented relationships to psychiatric illness within either 1) particular cortical cell types or 2) macro-dissected cortex. The full lists can be found in S7 (Table S1) The top diagnosis-related genes identified by models that include cell content predictions pinpoint known risk candidates
Although the inclusion of predicted cell type balance in our model occasionally improved our ability to detect previously-identified relationships with diagnosis, most relationships still went undetected in the Pritzker dataset and none of the diagnosis relationships survived standard p-value corrections for multiple comparisons. This could be due to a variety of factors, including microarray platform and probe sensitivity. Therefore, we decided to ask a complementary question: Of the top diagnosis relationships that we see in our dataset, how many have been previously observed in the literature? If including predicted cell type balance in our models improves the signal to noise ratio of our analyses, then we would expect that the top diagnosis-related genes in our dataset would be more likely to overlap with previous findings. To perform this comparison in an unbiased and efficient manner, we limited our search to PubMed, using as search terms only the respective human gene symbol and diagnosis ("Schizophrenia", "Bipolar", or "Depression"). For the genes related to MDD in our dataset, we also expanded the search to include two highly-correlated traits that are more quantifiable: "Anxiety" and "Suicide". Then we narrowed our results only to studies using human subjects.
Before controlling for cell type, when using a traditional model ("Model#2") we found that only one of the top 10 genes related to diagnosis (FOS: [103, 104] Fig N) , and 9/10 of the top genes were actually significant with an FDR<0.05 when using permutation based methods (using the R function lmp{lmPerm}, iterations=9999). The top 10 genes associated with psychiatric illness in models selected using forward/backward stepwise model selection (criterion=BIC) similarly included five that had been previously identified in the literature (PRSS16: [113] , GRM1: [108, 109] ; ALDH1A1: [105] ; SNAP25:
[110]; HIVEP2: [112] , a significant improvement in overlap with the literature than what can be seen in 100 randomly-selected genes in the dataset subjected to the same protocol (Fisher's exact test: 5/10 vs.15/100, p=0.0168).
Fig M.
When analyzing the full Pritzker dataset, the top genes associated with diagnosis in models that include cell content predictions include genes previously identified in the literature. Depicted are the top 10 genes associated with diagnosis using three different models of increasing complexity, along with their b's (magnitude and direction of effect within the model -blue=downregulation, pink=upregulation), nominal p-values, and p-values that have been corrected for false detection rate (FDR or q-value). Gene symbols that are bolded and highlighted yellow have been previously detected in the human literature in association with their respective diagnosis in papers identified using the PubMed search terms "Schizophrenia" (Row 1) and "Bipolar" (Row 2). None of the top genes associated with major depressive disorder in any of the three models were found to be associated with "Depression", "Anxiety", or "Suicide" on PubMed (Row 3). -0.15 6.04E-04 9.16E-01 MED24 0.14 7.86E-04 9.99E-01 ARL4D -0.13 9.74E-04 9.99E-01 NEURL 0.11 6.40E-04 9.16E-01 NKAIN1 0.11 7.97E-04 9.99E-01 MED24 0.13 1.06E-03 9.99E-01 NKAIN1 0.11 1.15E-03 9.16E-01 REC8 0.12 8.57E-04 9.99E-01 PRSS16 0.09 1.29E-03 9.99E-01 GGA3 0.09 1.59E-03 9.16E-01 FZD2 0.08 9.54E-04 9.99E-01 HBS1L -0.18 1.33E-03 9.99E-01 VENTXP1 -0.03 1.60E-03 9.16E-01 KCNN2 -0.14 1.19E-03 9.99E-01 NKAIN1 0.10 1.40E-03 9.99E-01 When analyzing the full dataset, the top genes associated with psychiatric illness in models that include cell content predictions include genes previously identified in the literature. Depicted are the top 10 genes associated with psychiatric illness using three different models of increasing complexity, or associated with psychiatric illness or suicide in models chosen using stepwise regression. Notably, the results from stepwise regression for the diagnosis term are not included in this figure because the term was only included in the model for eight genes total (DHX32, ID1, CSRP1, AKR1B10, TBPL1, HIST1H4F, SETD3, GAL). Formatting follows that of Fig M. Note that the p-values associated with stepwise regression are likely to be optimistic due to overfitting. Gene symbols that are bolded and highlighted yellow have been previously detected in the human literature using the PubMed search terms "Schizophrenia", "Bipolar", "Depression", "Anxiety", or "Suicide".
Together, we conclude that including cell content predictions in the analysis of macro-dissected microarray data can sometimes improve the sensitivity of the assay for detecting altered gene expression in relationship to psychiatric illness, especially if the dataset is confounded with dissection variation. 
